Visão selecionada em Inglês
| Descritor em português: | Antineoplásicos | ||||||
| Descritor em inglês: | Antineoplastic Agents | ||||||
| Descritor em espanhol: |
Antineoplásicos
| ||||||
| Descritor em francês: | Antinéoplasiques | ||||||
| Termo(s) alternativo(s): |
Agent, Anticancer Agent, Antineoplastic Agent, Antitumor Agent, Cancer Chemotherapy Agents, Anticancer Agents, Antineoplastic Agents, Antitumor Agents, Cancer Chemotherapy Agents, Chemotherapeutic Anticancer Anticancer Agent Anticancer Agents Antineoplastic Antineoplastic Agent Antineoplastic Drug Antineoplastic Drugs Antineoplastics Antitumor Agent Antitumor Agents Antitumor Drug Antitumor Drugs Cancer Chemotherapy Agent Cancer Chemotherapy Agents Cancer Chemotherapy Drug Cancer Chemotherapy Drugs Chemotherapeutic Anticancer Agents Chemotherapeutic Anticancer Drug Chemotherapy Agent, Cancer Chemotherapy Agents, Cancer Chemotherapy Drug, Cancer Chemotherapy Drugs, Cancer Drug, Antineoplastic Drug, Antitumor Drug, Cancer Chemotherapy Drug, Chemotherapeutic Anticancer Drugs, Antineoplastic Drugs, Antitumor Drugs, Cancer Chemotherapy |
||||||
| Código(s) hierárquico(s): |
D27.505.954.248 |
||||||
| Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D000970 | ||||||
| Nota de escopo: | Substances that inhibit or prevent the proliferation of NEOPLASMS. |
||||||
| Nota de indexação: | /admin: various administration procedures are available, as CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CHEMOEMBOLIZATION, THERAPEUTIC and INFUSIONS, INTRA-ARTERIAL; for combined anticancer agents, ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS is available; Manual 24.4.2.1+ |
||||||
| Qualificadores permitidos: |
AD administration & dosage AE adverse effects AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Versão alternativa: | ANTINEOPL AGENTS |
||||||
| Veja também os descritores: |
Anticarcinogenic Agents
MeSH Chemoembolization, Therapeutic MeSH Chemotherapy, Cancer, Regional Perfusion MeSH Cytotoxins MeSH Infusions, Intra-Arterial MeSH Tumor Lysis Syndrome MeSH | ||||||
| Identificador DeCS: | 974 | ||||||
| ID do descritor: | D000970 | ||||||
| Classificação da NLM: | QV 269 | ||||||
| Documentos indexados na Biblioteca Virtual em Saúde (BVS): | Clique aqui para acessar os documentos da BVS | ||||||
| Data de estabelecimento: | 01/01/1966 | ||||||
| Data de entrada: | 01/01/1999 | ||||||
| Data de revisão: | 27/05/2020 |
-
-
CHEMICALS AND DRUGS
Chemical Actions and Uses [D27]Chemical Actions and Uses
|
|
Antineoplastic Agents
- Conceito preferido
| Identificador do conceito |
M0001483 |
| Nota de escopo | Substances that inhibit or prevent the proliferation of NEOPLASMS. |
| Termo preferido | Antineoplastic Agents |
| Termo(s) alternativo(s) |
Agent, Anticancer Agent, Antineoplastic Agent, Antitumor Agent, Cancer Chemotherapy Agents, Anticancer Agents, Antineoplastic Agents, Antitumor Agents, Cancer Chemotherapy Agents, Chemotherapeutic Anticancer Anticancer Agent Anticancer Agents Antineoplastic Antineoplastic Agent Antineoplastic Drug Antineoplastic Drugs Antineoplastics Antitumor Agent Antitumor Agents Antitumor Drug Antitumor Drugs Cancer Chemotherapy Agent Cancer Chemotherapy Agents Cancer Chemotherapy Drug Cancer Chemotherapy Drugs Chemotherapeutic Anticancer Agents Chemotherapeutic Anticancer Drug Chemotherapy Agent, Cancer Chemotherapy Agents, Cancer Chemotherapy Drug, Cancer Chemotherapy Drugs, Cancer Drug, Antineoplastic Drug, Antitumor Drug, Cancer Chemotherapy Drug, Chemotherapeutic Anticancer Drugs, Antineoplastic Drugs, Antitumor Drugs, Cancer Chemotherapy |
Queremos a sua opinião sobre o novo sitio web do DeCS/MeSH
Convidamos-lhe a responder a uma pesquisa que não levará mais que 3 minutos
Ir para pesquisa
